Postchallenge hyperglycemia but not hyperinsulinemia is associated with angiographically documented coronary atherosclerosis in Korean subjects

Diabetes Research and Clinical Practice

Volumn 59, Issue 2, 2003, Pages 129-136

  Kim, Hong Kyu ^a   Lee, Sung Kwang ^a   Suh, Chan Jong ^a   Yoon, Hyo Joong ^a   Lee, Ki Young ^a   Park, Hye Young ^a   Kang, Moon Ho ^a  

^a Gachon University College of Medicine   (South Korea)

Author keywords

Angiographically documented; Coronary atherosclerosis; Hyperinsulinemia; Postchallenge hyperglycemia

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CHOLESTEROL; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; HYPERINSULINISM; INSULIN; KOREA; MALE; MIDDLE AGED; SEX FACTORS; TRIGLYCERIDES;

EID: 0037304622     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(02)00199-7     Document Type: Article

References (33)

1. Stout R.W. Insulin and atheroma-20 yr perspective. Diabetes care. 13:1990;631-654.
2. Fontbonne A., Charles M.A., Thibult N., et al. Hyperinsulinemia as a predictor of coronary heart disease mortality in a healthy population: the Paris prospective study, 15-year follow-up. Diabetologia. 34:1991;356-361.
3. Despres J.P., Lamarche B., Mauriege P., et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N. Engl. J. Med. 334:1996;952-957.
4. Zavaroni I., Bonora E., Pagliara M., et al. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N. Engl. J. Med. 321:1989;616-618.
5. Laakso M., Sarlund H., Salonen R., et al. Asymptomatic atherosclerosis and insulin resistance. Arterioscler Thromb. 11:1991;1068-1076.
6. Raal F.J., Panz V.R., Pilcher G.J., Joffe B.I. Atherosclerosis seems not to be associated with hyperinsulinemia in patients with familial hypercholesterolemia. J. Intern. Med. 246:1999;75-80.
7. Welin L., Eriksson H., Larsson B., Ohlson L.O., Svardsudd K., Tibblin G. Hyperinsulinemia is not a major coronary risk factor in elderly men. The study of men born in 1913. Diabetologia. 35:1992;766-770.
8. Mookherjee S., Potts J.L., Hill N.E., et al. Lack of relationship between plasma insulin and glucagon levels and angiographically-documented coronary artery atherosclerosis. Atherosclerosis. 53:1984;99-109.
9. Shinozaki K., Suzuki M., Ikebuchi M., Hara Y., Harano Y. Demonstration of insulin resistance in coronary artery disease documented with angiography. Diabetes Care. 19:1996;1-7.
10. Bressler P., Bailey S.R., Matsuda M., DeFronzo R.A. Insulin resistance and coronary artery disease. Diabetologia. 39:1996;1345-1350.
11. Seibaek M., Sloth C., Vallebo L., et al. Glucose tolerance status and severity of coronary artery disease in men referred to coronary angiography. Am. Heart J. 133:1997;622-629.
12. Takezako T., Saku K., Zhang B., Shirai K., Arakawa K. Insulin resistance and angiographical characteristics of coronary atherosclerosis. Jpn. Circ. J. 63:1999;666-673.
13. Min H.K. Non-insulin-dependent diabetes mellitus in Korea. Diabet. Med. 13:1996;S13-S15.
14. Kim D.J., Lee M.S., Kim K.W., Lee M.K. Insulin secretory dysfunction and insulin resistance in the pathogenesis of Korean type 2 diabetes mellitus. Metabolism. 50:2001;590-593.
15. Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes. 48:1999;937-942.
16. Barrett-Connor A., Ferrara A. Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. Diabetes Care. 21:1998;1236-1239.
17. Shaw J.E., Hodge A.M., de Courten M., Chitson P., Simmet P.Z. Isolated post-challenge hyperglycemia confirmed as a risk factor for mortality. Diabetologia. 42:1999;1050-1054.
18. Tominaga M., Eguchi H., Manaka H., Igarash K., Kato T., Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. Diabetes Care. 22:1999;920-924.
19. Saydah S., Miret M., Sung J., Varas C., Gause D., Brancati F. Postchallange hyperglycemia and mortality in a national sample of US adults. Diabetes Care. 24:2001;1397-1402.
20. Temelkova-Kurkschiev T.S., Kehler C., Henkel E., Leonhard W., Fuecker K., Hanefeld M. Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care. 23:2000;1830-1834.
21. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:1985;412-419.
22. Matsumoto K., Miyake S., Yano M., et al. Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese Subjects. Diabetes Care. 20:1997;562-1568.
23. Stout R.W. The relationship of abnormal circulating insulin levels to atherosclerosis. Atherosclerosis. 27:1997;1-13.
24. Laakso M., Pyorala K., Voutilainen E., Marniemi J. Plasma insulin, serum lipids and lipoproteins in middle-aged non-insulin dependent diabetic and non-diabetic subjects. Am. J. Epidemiol. 125:1987;611-621.
25. Shen D.C., Shieh S.M., Fuh M.M.-T., Wu D.-A., Chen Y.-D.L., Reaven G.M. Resistance to insulin-stimulated glucose uptake in patients with hypertension. J. Clin. Endocrinol. Metab. 66:1988;580-583.
26. Harano Y., Kijima H., Kosugi K., et al. Hyperlipidemia and atherosclerosis in experimental insulinopenic diabetic monkeys. Diabetes. Res. Clin. Pract. 16:1992;163-173.
27. Kuusisto J., Mykkanen L., Pyorala K., Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes. 43:1994;960-967.
28. Andersson D.K.G., Svardsudd K. Long-term glycemic control relates to mortality in type II diabetes. Diabetes Care. 18:1995;1534-1543.
29. Coutinho M., Gerstein H.C., Wang Y., Yusuf S. The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care. 22:1999;233-240.
30. Stratton I.M., Adler A.I., Neil H.A. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 321:2000;405-412.
31. Bayes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes. 40:1991;405-412.
32. Vlassara H. Recent progress in advanced glycation end products and diabetic complications. Diabetes. 46:(Suppl. 2):1997;S19-S25.
33. Koya D., King G.L. Protein kinase C and the development of diabetic complications. Diabetes. 47:1998;856-866.